See some of the latest developments, discoveries and commentaries from the WashU Medicine Department of Obstetrics and Gynecology.
For more news and updates:
Follow us on Twitter »
Listen to our Podcast »
Subscribe to our newsletter »
Media contact:
Jessica Church, Director of Media Relations – WashU Medicine Marketing & Communications
j.church@wustl.edu
WashU OB/GYN Researchers Examine Cervical Cancer Screening Preferences in Transgender, Nonbinary, and Gender-diverse Patients
New research from WashU OB/GYN explores how transgender and gender-diverse patients prefer to be screened for cervical cancer. In this L.A.B. Award-funded survey study of 50 patients receiving care at the Washington University Transgender Center, we sought to describe their cervical cancer screening preferences. The majority of respondents preferred self-collected HPV tests for cervical cancer […]
Jeannie Kelly, MD, MS, Co-Authors First Real-World Study on Hepatitis C Treatment in Pregnancy
Jeannie Kelly, MD, MS, Chief of Maternal-Fetal Medicine, Washington University in St. Louis, co-authored a new study published in Clinical Infectious Diseases examining glecaprevir-pibrentasvir (GLE/PIB) for hepatitis C treatment during pregnancy. The retrospective report, the first of its kind on this drug combination in pregnant patients, followed 14 women treated at WashU Medicine between 2024 […]
Meet Chetan Giduturi
Meet Chetan Giduturi, our gynecologic oncology visiting student scholar. This program providers visiting fourth-year medical students with a four-week rotation with WashU Medicine Gynecologic Oncology. This opportunity provides funding and networking opportunities while fostering a collaborative and supportive learning environment. Students rotate through inpatient care for a large gynecologic oncology service, assist in surgery, participate […]
FY26 Q4 Newsletter (Links to an external site)
Check out our quarter four newsletter!
WashU Awarded NIH Grant to Test New Tool for Keeping New Moms in Addiction Treatment
Washington University School of Medicine has received NIH/NIDA funding for a randomized controlled trial testing Contingency Management, a proven incentive-based treatment approach, to help pregnant and postpartum patients with substance use disorder stay in treatment longer. Overdose is a top-three cause of pregnancy-associated death, and up to 80% of patients stop treatment within a year […]